{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:19:38Z","timestamp":1790803178544,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.rmr.2014.10.733","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T11:31:20Z","timestamp":1432207880000},"page":"557-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Consensus national sur la prescription de l\u2019azithromycine dans la mucoviscidose"],"prefix":"10.1016","volume":"32","author":[{"given":"M.","family":"Abely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Jubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bessaci-Kabouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2014.10.733_bib0270","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0761-8425(08)73800-2","article-title":"Mesure de l\u2019inflammation pulmonaire dans la mucoviscidose","volume":"25","author":"Fayon","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2014.10.733_bib0275","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S1286-4579(99)80518-8","article-title":"Pathogenicity of microbes associated with cystic fibrosis","volume":"1","author":"Hutchison","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.rmr.2014.10.733_bib0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1286-4579(00)01349-6","article-title":"Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth","volume":"3","author":"Hoiby","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.rmr.2014.10.733_bib0285","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1128\/IAI.00909-06","article-title":"Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia","volume":"74","author":"Bonnett","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.rmr.2014.10.733_bib0290","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/600380","article-title":"Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection","volume":"200","author":"Mircescu","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.rmr.2014.10.733_bib0295","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/CMR.00014-09","article-title":"Innate immunity to Aspergillus species","volume":"22","author":"Park","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.rmr.2014.10.733_bib0300","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1172\/JCI112603","article-title":"In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism","volume":"78","author":"Schaffner","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2014.10.733_bib0305","first-page":"5S","article-title":"Clinical implications of the immunomodulatory effects of macrolides","volume":"117","author":"Tamaoki","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.rmr.2014.10.733_bib0310","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/AAC.01011-06","article-title":"Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P.\u00a0aeruginosa lung infection in Cftr(\u2212\/\u2212) mice","volume":"51","author":"Hoffmann","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rmr.2014.10.733_bib0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ppul.20620","article-title":"Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes","volume":"42","author":"Nguyen","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s101560050042","article-title":"Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response","volume":"6","author":"Tateda","year":"2000","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.rmr.2014.10.733_bib0325","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1378\/chest.128.2.912","article-title":"Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients","volume":"128","author":"Wagner","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2014.10.733_bib0330","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/thoraxjnl-2013-204517","article-title":"The impact of azithromycin therapy on the airway microbiota in asthma","volume":"69","author":"Slater","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2014.10.733_bib0335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2008-0357OC","article-title":"Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection","volume":"42","author":"Halldorsson","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0340","doi-asserted-by":"crossref","first-page":"265714","DOI":"10.1155\/2012\/265714","article-title":"Azithromycin inhibits mucus hypersecretion from airway epithelial cells","volume":"2012","author":"Shimizu","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.rmr.2014.10.733_bib0345","first-page":"S48","article-title":"Macrolides, Pseudomonas aeruginosa et mucoviscidose\u00a0: concepts actuels","volume":"13","author":"Guillot","year":"2006","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.rmr.2014.10.733_bib0350","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.2005.057950","article-title":"Long-term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial","volume":"61","author":"Clement","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2014.10.733_bib0355","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.arcped.2013.12.023","article-title":"Pourquoi utiliser les macrolides au long cours en pneumologie p\u00e9diatrique\u00a0?","volume":"21","author":"Corvol","year":"2014","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.rmr.2014.10.733_bib0360","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long-term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2014.10.733_bib0365","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","article-title":"Long-term azithromycin may improve lung function in children with cystic fibrosis","volume":"351","author":"Jaffe","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2014.10.733_bib0370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2009.09.001","article-title":"Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial","volume":"9","author":"Kabra","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2014.10.733_bib0375","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1183\/09031936.00163306","article-title":"Daily versus weekly azithromycin in cystic fibrosis patients","volume":"30","author":"McCormack","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2014.10.733_bib0380","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2014.10.733_bib0385","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.rmed.2008.03.009","article-title":"Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection","volume":"102","author":"Steinkamp","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2014.10.733_bib0390","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2014.10.733_bib0395","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","author":"Southern","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2014.10.733_bib0400","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2014.10.733_bib0405","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2008.09.005","article-title":"European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis","volume":"8","author":"Mayell","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2014.10.733_bib0410","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/0924-8579(93)90039-8","article-title":"Therapeutic possibilities for diffuse panbronchiolitis","volume":"3","author":"Kobayashi","year":"1993","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.rmr.2014.10.733_bib0415","first-page":"551","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response","volume":"82","author":"Hoiby","year":"1974","journal-title":"Acta Pathol Microbiol Scand [B]"},{"key":"10.1016\/j.rmr.2014.10.733_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.10.027","article-title":"Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells","volume":"674","author":"Saint-Criq","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0425","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1165\/rcmb.2003-0105OC","article-title":"Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release","volume":"30","author":"Yamasawa","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0430","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/dkl014","article-title":"Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis","volume":"57","author":"Phaff","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmr.2014.10.733_bib0435","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0002-9343(00)00724-5","article-title":"Hypersensitivity syndrome associated with azithromycin","volume":"110","author":"Cascaval","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.rmr.2014.10.733_bib0440","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1023\/A:1020170807742","article-title":"Azithromycin-induced intrahepatic cholestasis","volume":"47","author":"Chandrupatla","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rmr.2014.10.733_bib0445","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0091-6749(93)90345-G","article-title":"Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma","volume":"91","author":"Kamada","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0450","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2146\/ajhp080687","article-title":"Azithromycin-induced liver injury","volume":"67","author":"Lockwood","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.rmr.2014.10.733_bib0455","first-page":"217","article-title":"Azithromycin-induced intrahepatic cholestasis","volume":"102","author":"Longo","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.rmr.2014.10.733_bib0460","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-199920010-00004","article-title":"Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients","volume":"20","author":"Principi","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.rmr.2014.10.733_bib0465","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ppul.21620","article-title":"Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects","volume":"47","author":"Wilms","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0470","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prrv.2009.12.003","article-title":"The role of azithromycin in patients with cystic fibrosis","volume":"11","author":"Yousef","year":"2010","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.rmr.2014.10.733_bib0475","article-title":"How long should we maintain long-term azithromycin treatment in cystic fibrosis patients?","author":"Willekens","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0480","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pupt.2009.03.002","article-title":"Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis","volume":"22","author":"Florescu","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmr.2014.10.733_bib0485","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcf.2008.09.001","article-title":"Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients","volume":"8","author":"Hansen","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2014.10.733_bib0490","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":"Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function","volume":"26","author":"Tramper-Stranders","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.rmr.2014.10.733_bib0495","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/JCM.03318-13","article-title":"Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis","volume":"52","author":"Touati","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0500","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1183\/09031936.00065612","article-title":"Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients","volume":"41","author":"Catherinot","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2014.10.733_bib0505","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/rccm.201307-1200OC","article-title":"Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis","volume":"188","author":"Binder","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2014.10.733_bib0510","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0954-6111(99)90270-6","article-title":"Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients","volume":"93","author":"Bargon","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2014.10.733_bib0515","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ppul.21240","article-title":"Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis","volume":"45","author":"Jubin","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2014.10.733_bib0520","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1177\/1060028013504905","article-title":"Azithromycin-induced proarrhythmia and cardiovascular death","volume":"47","author":"Howard","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rmr.2014.10.733_bib0525","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1164\/rccm.201402-0385CI","article-title":"Macrolide antibiotics and the risk of cardiac arrhythmias","volume":"189","author":"Albert","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2014.10.733_bib0265","first-page":"581","article-title":"Cardiovascular risks with azithromycin","volume":"369","author":"Mosholder","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842515000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842515000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T12:51:53Z","timestamp":1537620713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842515000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0761842515000352"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2014.10.733","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus national sur la prescription de l\u2019azithromycine dans la mucoviscidose","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2014.10.733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}